Literature DB >> 20521124

Effects of PACAP in UV-A radiation-induced retinal degeneration models in rats.

Tamas Atlasz1, Krisztina Szabadfi, Peter Kiss, Zsuzsanna Marton, Monika Griecs, Levente Hamza, Valeria Gaal, Zsolt Biro, Andrea Tamas, Gabor Hild, Miklos Nyitrai, Gabor Toth, Dora Reglodi, Robert Gabriel.   

Abstract

The retina is constantly exposed to ultraviolet (UV) light with different wavelengths, which may lead to chronic UV-induced retinal injury. In our previous studies, we have shown the protective effects of pituitary adenylate cyclase activating polypeptide (PACAP) in toxic and ischemic retinal injuries. The aim of the present study was to investigate the effects of PACAP in UV-A-induced retinal lesion. We used diffuse UV-A radiation (315-400 nm) to induce acute retinal damage over a short period of exposure. Using standard histological (morphological and morphometrical) analysis, we assessed the actions of intravitreal PACAP (100 pmol/5 µl) treatment on acute UV-A-induced retinal damage. We measured the thickness of nuclear and plexiform layers as well as the number of cells in the outer nuclear and inner nuclear layers and in the ganglion cell layer. Outer limiting membrane-inner limiting membrane distances in the cross-section of the retina were also examined. Our results show that UV-A light-induced retinal damage led to severe degeneration in the photoreceptor layer, and in the outer and inner nuclear layers. Alteration in the plexiform layers was also observed. We found that post-irradiation PACAP treatment significantly attenuated the UV-A-induced retinal damage. Our results provide the basis for future clinical application of PACAP treatment in retinal degeneration and may have clinical implications in several ophthalmic diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20521124     DOI: 10.1007/s12031-010-9392-3

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  51 in total

1.  Gene expression for PACAP receptor mRNA in the rat retina by in situ hybridization and in situ RT-PCR.

Authors:  T Seki; S Izumi; S Shioda; C J Zhou; A Arimura; R Koide
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

2.  The resistance of transferrin, lactoferrin and caeruloplasmin to oxidative damage.

Authors:  B Halliwell; O I Aruoma; M Wasil; J M Gutteridge
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

3.  Search for the optimal monosodium glutamate treatment schedule to study the neuroprotective effects of PACAP in the retina.

Authors:  Norbert Babai; Tamas Atlasz; Andrea Tamás; Dora Reglodi; Gabor Tóth; Peter Kiss; Robert Gábriel
Journal:  Ann N Y Acad Sci       Date:  2006-07       Impact factor: 5.691

4.  Pituitary adenylate cyclase-activating peptide (PACAP) stimulates production of interleukin-6 in rat Müller cells.

Authors:  Masayoshi Nakatani; Tamotsu Seki; Yuko Shinohara; Chisato Taki; Shigeru Nishimura; Atsushi Takaki; Seiji Shioda
Journal:  Peptides       Date:  2006-01-19       Impact factor: 3.750

5.  Protection of rat retina from ischemia-reperfusion injury by vasoactive intestinal peptide (VIP): the effect of VIP on lipid peroxidation and antioxidant enzyme activity of retina and choroid.

Authors:  N Tunçel; H Başmak; K Uzuner; M Tunçel; G Altiokka; V Zaimoğlu; A Ozer; F Gürer
Journal:  Ann N Y Acad Sci       Date:  1996-12-26       Impact factor: 5.691

6.  A fluoroquinolone antibiotic with a methoxy group at the 8 position yields reduced generation of 8-oxo-7,8-dihydro-2'-deoxyguanosine after ultraviolet-A irradiation.

Authors:  J E Rosen; D Chen; A K Prahalad; T E Spratt; G Schluter; G M Williams
Journal:  Toxicol Appl Pharmacol       Date:  1997-08       Impact factor: 4.219

7.  Inhibition by singlet oxygen quenchers of oxidative damage to DNA produced in cultured cells by exposure to a quinolone antibiotic and ultraviolet A irradiation.

Authors:  L K Verna; D Chen; G Schluter; G M Williams
Journal:  Cell Biol Toxicol       Date:  1998-06       Impact factor: 6.691

8.  Evaluation of the protective effects of PACAP with cell-specific markers in ischemia-induced retinal degeneration.

Authors:  Tamas Atlasz; Krisztina Szabadfi; Peter Kiss; Andrea Tamas; Gabor Toth; Dora Reglodi; Robert Gabriel
Journal:  Brain Res Bull       Date:  2009-09-12       Impact factor: 4.077

9.  PACAP-mediated neuroprotection of neurochemically identified cell types in MSG-induced retinal degeneration.

Authors:  Tamas Atlasz; Krisztina Szabadfi; Peter Kiss; Norbert Babai; Zsombor Koszegi; Andrea Tamas; Dora Reglodi; Robert Gabriel
Journal:  J Mol Neurosci       Date:  2008-04-17       Impact factor: 3.444

10.  Posterior cataract induction by UV-B radiation in albino mice.

Authors:  J G Jose
Journal:  Exp Eye Res       Date:  1986-01       Impact factor: 3.467

View more
  15 in total

1.  Effects of PACAP on intracellular signaling pathways in human retinal pigment epithelial cells exposed to oxidative stress.

Authors:  E Fabian; D Reglodi; L Mester; A Szabo; K Szabadfi; A Tamas; G Toth; K Kovacs
Journal:  J Mol Neurosci       Date:  2012-05-29       Impact factor: 3.444

2.  Reduced Disc Shedding and Phagocytosis of Photoreceptor Outer Segment Contributes to Kava Kava Extract-induced Retinal Degeneration in F344/N Rats.

Authors:  Haruhiro Yamashita; Mark J Hoenerhoff; Keith R Shockley; Shyamal D Peddada; Kevin E Gerrish; Deloris Sutton; Connie A Cummings; Yu Wang; Foley F Julie; Mamta Behl; Suramya Waidyanatha; Robert C Sills; Arun R Pandiri
Journal:  Toxicol Pathol       Date:  2018-05-27       Impact factor: 1.902

3.  Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo.

Authors:  K Szabadfi; T Atlasz; P Kiss; B Danyadi; A Tamas; Zs Helyes; H Hashimoto; N Shintani; A Baba; G Toth; R Gabriel; D Reglodi
Journal:  Neurotox Res       Date:  2011-06-30       Impact factor: 3.911

4.  Pleiotropic functions of pituitary adenylyl cyclase-activating polypeptide on retinal ontogenesis: involvement of KLF4 in the control of progenitor cell proliferation.

Authors:  Brian Njaine; Maurício Rocha-Martins; Carlos H Vieira-Vieira; Luiz D Barbosa De-Melo; Rafael Linden; Karen Braas; Victor May; Rodrigo A P Martins; Mariana S Silveira
Journal:  J Mol Neurosci       Date:  2014-04-09       Impact factor: 3.444

5.  Protective effects of vasoactive intestinal peptide (VIP) in ischemic retinal degeneration.

Authors:  K Szabadfi; B Danyadi; P Kiss; A Tamas; E Fabian; R Gabriel; D Reglodi
Journal:  J Mol Neurosci       Date:  2012-04-29       Impact factor: 3.444

6.  The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration.

Authors:  A Vaczy; D Reglodi; T Somoskeoy; K Kovacs; E Lokos; E Szabo; A Tamas; T Atlasz
Journal:  J Mol Neurosci       Date:  2016-08-26       Impact factor: 3.444

7.  PACAP Is Protective in a Rat Model of Retinopathy of Prematurity.

Authors:  Timea Kvarik; Barbara Mammel; Dora Reglodi; Krisztina Kovacs; Dora Werling; Brigitta Bede; Alexandra Vaczy; Eszter Fabian; Gabor Toth; Peter Kiss; Andrea Tamas; Tibor Ertl; Judit Gyarmati; Tamas Atlasz
Journal:  J Mol Neurosci       Date:  2016-08-25       Impact factor: 3.444

8.  PACAP attenuates NMDA-induced retinal damage in association with modulation of the microglia/macrophage status into an acquired deactivation subtype.

Authors:  Yoshihiro Wada; Tomoya Nakamachi; Kimi Endo; Tamotsu Seki; Hirokazu Ohtaki; Daisuke Tsuchikawa; Motohide Hori; Masashi Tsuchida; Akira Yoshikawa; Attila Matkovits; Nobuyuki Kagami; Nori Imai; Shiho Fujisaka; Isao Usui; Kazuyuki Tobe; Ryohei Koide; Haruo Takahashi; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2013-05-30       Impact factor: 3.444

Review 9.  PACAP and NAP: Effect of Two Functionally Related Peptides in Diabetic Retinopathy.

Authors:  Agata Grazia D'Amico; Grazia Maugeri; Giuseppe Musumeci; Dora Reglodi; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2021-01-05       Impact factor: 3.444

10.  Distribution and protective function of pituitary adenylate cyclase-activating polypeptide in the retina.

Authors:  Tomoya Nakamachi; Attila Matkovits; Tamotsu Seki; Seiji Shioda
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-23       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.